{"id":51041,"date":"2021-04-29T22:55:10","date_gmt":"2021-04-30T02:55:10","guid":{"rendered":"https:\/\/www.med.unc.edu\/medicine\/?p=51041"},"modified":"2023-06-06T18:09:00","modified_gmt":"2023-06-06T22:09:00","slug":"g1-therapeutics-announces-publication-of-pooled-results-from-pivotal-clinical-program-of-cosela-trilaciclib-in-clinical-lung-cancer","status":"publish","type":"post","link":"https:\/\/www.med.unc.edu\/medicine\/news\/g1-therapeutics-announces-publication-of-pooled-results-from-pivotal-clinical-program-of-cosela-trilaciclib-in-clinical-lung-cancer\/","title":{"rendered":"G1 Therapeutics Announces Publication of Pooled Results from Pivotal Clinical Program of COSELA\u2122 (trilaciclib) in Clinical Lung Cancer"},"content":{"rendered":"<figure id=\"attachment_41040\" class=\"thumbnail wp-caption alignright\" style=\"width: 310px\"><a href=\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2020\/03\/jared-weiss-LCCC-photo.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"size-medium wp-image-41040\" src=\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2020\/03\/jared-weiss-LCCC-photo-300x232.jpg\" alt=\"jared-weiss-LCCC-photo\" width=\"300\" height=\"232\" \/><\/a><figcaption class=\"caption wp-caption-text\">Jared Weiss, MD<\/figcaption><\/figure>\n<p>G1 Therapeutics, Inc., a commercial-stage oncology company, <a href=\"https:\/\/www.biospace.com\/article\/releases\/g1-therapeutics-announces-publication-of-pooled-results-from-pivotal-clinical-program-of-cosela-trilaciclib-in-clinical-lung-cancer\/?s=86\">announced that the peer-reviewed journal<\/a> of <em>Clinical Lung Cancer<\/em> published the final pooled results from three clinical trials of COSELA\u2122 (trilaciclib) in extensive-stage small cell lung cancer (ES-SCLC).<\/p>\n<p>\u201cCancer patients have two major sources of physical suffering &#8211; the cancer itself and the side effects of chemotherapy,\u201d said first author <a href=\"https:\/\/www.med.unc.edu\/medicine\/directory\/jared-weiss-md\/\">Jared Weiss<\/a>, MD, associate professor of medicine in the division of oncology and member of the Lineberger Comprehensive Cancer Center, in a press announcement published in <a href=\"https:\/\/www.biospace.com\/article\/releases\/g1-therapeutics-announces-publication-of-pooled-results-from-pivotal-clinical-program-of-cosela-trilaciclib-in-clinical-lung-cancer\/?s=86\">BioSpace News<\/a>.<\/p>\n<p>\u201cSmall cell tends to present with bulky and rapidly growing central chest disease, which can compress airways and major vessels leading to shortness of breath, cough, and pain. While chemotherapy is great at shrinking the cancer and relieving these symptoms, it comes at the cost of side effects. The most common side effects from chemotherapy are suppression of blood counts and the consequences of that &#8211; neutropenia, anemia and fatigue. Trilaciclib helps decrease these side effects which can help optimize quality of life. With trilaciclib added to standard therapy, my patients experience less hematologic toxicity, a reduced need for supportive care interventions and hospitalizations due to CIM or sepsis, and ultimately improvements in health-related quality of life domains, including fatigue, and physical and functional well-being.\u201d<\/p>\n<p>The <em>Clinical Lung Cancer<\/em> article, &#8220;Effects of Trilaciclib on Chemotherapy-Induced Myelosuppression and Patient-Reported Outcomes in Patients with Extensive-Stage Small Cell Lung Cancer: Pooled Results from Three Phase 2 Randomized, Double-Blind, Placebo-Controlled Studies&#8221; can be found <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=450bS3WSVpEriWntQDY_6XHHPKDzV5Xg2XoQ9fsCha2GF30qbseMQYXXztTwpSPBEkUG0TWdH1iSZhjMrKv84zLWqDXUJvScfDPmXNah3OhpgF3iV5hHp0MDDuDt4_q1UPd5YhHt6fU76SuqWrsH7w==\" target=\"_blank\" rel=\"nofollow noopener noreferrer\">here<\/a>.<\/p>\n<p>Read the press announcement <a href=\"https:\/\/www.biospace.com\/article\/releases\/g1-therapeutics-announces-publication-of-pooled-results-from-pivotal-clinical-program-of-cosela-trilaciclib-in-clinical-lung-cancer\/?s=86\">here<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>G1 Therapeutics, Inc., a commercial-stage oncology company, announced that the peer-reviewed journal of Clinical Lung Cancer published the final pooled results from three clinical trials of COSELA\u2122 (trilaciclib) in extensive-stage small cell lung cancer (ES-SCLC). \u201cCancer patients have two major sources of physical suffering &#8211; the cancer itself and the side effects of chemotherapy,\u201d said &hellip; <a href=\"https:\/\/www.med.unc.edu\/medicine\/news\/g1-therapeutics-announces-publication-of-pooled-results-from-pivotal-clinical-program-of-cosela-trilaciclib-in-clinical-lung-cancer\/\" aria-label=\"Read more about G1 Therapeutics Announces Publication of Pooled Results from Pivotal Clinical Program of COSELA\u2122 (trilaciclib) in Clinical Lung Cancer\">Read more<\/a><\/p>\n","protected":false},"author":69419,"featured_media":41040,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"layout":"","cellInformation":"","apiCallInformation":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[2,517],"tags":[630],"class_list":["post-51041","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-oncology","tag-630","odd"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>G1 Therapeutics Announces Publication of Pooled Results from Pivotal Clinical Program of COSELA\u2122 (trilaciclib) in Clinical Lung Cancer | Department of Medicine<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.med.unc.edu\/medicine\/news\/g1-therapeutics-announces-publication-of-pooled-results-from-pivotal-clinical-program-of-cosela-trilaciclib-in-clinical-lung-cancer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"G1 Therapeutics Announces Publication of Pooled Results from Pivotal Clinical Program of COSELA\u2122 (trilaciclib) in Clinical Lung Cancer | Department of Medicine\" \/>\n<meta property=\"og:description\" content=\"G1 Therapeutics, Inc., a commercial-stage oncology company, announced that the peer-reviewed journal of Clinical Lung Cancer published the final pooled results from three clinical trials of COSELA\u2122 (trilaciclib) in extensive-stage small cell lung cancer (ES-SCLC). \u201cCancer patients have two major sources of physical suffering &#8211; the cancer itself and the side effects of chemotherapy,\u201d said &hellip; Read more\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.med.unc.edu\/medicine\/news\/g1-therapeutics-announces-publication-of-pooled-results-from-pivotal-clinical-program-of-cosela-trilaciclib-in-clinical-lung-cancer\/\" \/>\n<meta property=\"og:site_name\" content=\"Department of Medicine\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/UNCDeptMedicine\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-30T02:55:10+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-06-06T22:09:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2020\/03\/jared-weiss-LCCC-photo-e1640101386432.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"867\" \/>\n\t<meta property=\"og:image:height\" content=\"929\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Kim Morris\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@uncdeptmedicine\" \/>\n<meta name=\"twitter:site\" content=\"@uncdeptmedicine\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Kim Morris\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/g1-therapeutics-announces-publication-of-pooled-results-from-pivotal-clinical-program-of-cosela-trilaciclib-in-clinical-lung-cancer\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/g1-therapeutics-announces-publication-of-pooled-results-from-pivotal-clinical-program-of-cosela-trilaciclib-in-clinical-lung-cancer\/\"},\"author\":{\"name\":\"Kim Morris\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/9a358414a53d5237f9ba3f8daa55c529\"},\"headline\":\"G1 Therapeutics Announces Publication of Pooled Results from Pivotal Clinical Program of COSELA\u2122 (trilaciclib) in Clinical Lung Cancer\",\"datePublished\":\"2021-04-30T02:55:10+00:00\",\"dateModified\":\"2023-06-06T22:09:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/g1-therapeutics-announces-publication-of-pooled-results-from-pivotal-clinical-program-of-cosela-trilaciclib-in-clinical-lung-cancer\/\"},\"wordCount\":278,\"image\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/g1-therapeutics-announces-publication-of-pooled-results-from-pivotal-clinical-program-of-cosela-trilaciclib-in-clinical-lung-cancer\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2020\/03\/jared-weiss-LCCC-photo-e1640101386432.jpg\",\"keywords\":[\"2021\"],\"articleSection\":[\"News\",\"Oncology\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/g1-therapeutics-announces-publication-of-pooled-results-from-pivotal-clinical-program-of-cosela-trilaciclib-in-clinical-lung-cancer\/\",\"url\":\"https:\/\/www.med.unc.edu\/medicine\/news\/g1-therapeutics-announces-publication-of-pooled-results-from-pivotal-clinical-program-of-cosela-trilaciclib-in-clinical-lung-cancer\/\",\"name\":\"G1 Therapeutics Announces Publication of Pooled Results from Pivotal Clinical Program of COSELA\u2122 (trilaciclib) in Clinical Lung Cancer | Department of Medicine\",\"isPartOf\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/g1-therapeutics-announces-publication-of-pooled-results-from-pivotal-clinical-program-of-cosela-trilaciclib-in-clinical-lung-cancer\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/g1-therapeutics-announces-publication-of-pooled-results-from-pivotal-clinical-program-of-cosela-trilaciclib-in-clinical-lung-cancer\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2020\/03\/jared-weiss-LCCC-photo-e1640101386432.jpg\",\"datePublished\":\"2021-04-30T02:55:10+00:00\",\"dateModified\":\"2023-06-06T22:09:00+00:00\",\"author\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/9a358414a53d5237f9ba3f8daa55c529\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/g1-therapeutics-announces-publication-of-pooled-results-from-pivotal-clinical-program-of-cosela-trilaciclib-in-clinical-lung-cancer\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.med.unc.edu\/medicine\/news\/g1-therapeutics-announces-publication-of-pooled-results-from-pivotal-clinical-program-of-cosela-trilaciclib-in-clinical-lung-cancer\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/g1-therapeutics-announces-publication-of-pooled-results-from-pivotal-clinical-program-of-cosela-trilaciclib-in-clinical-lung-cancer\/#primaryimage\",\"url\":\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2020\/03\/jared-weiss-LCCC-photo-e1640101386432.jpg\",\"contentUrl\":\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2020\/03\/jared-weiss-LCCC-photo-e1640101386432.jpg\",\"width\":867,\"height\":929,\"caption\":\"Jared Weiss, MD\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/g1-therapeutics-announces-publication-of-pooled-results-from-pivotal-clinical-program-of-cosela-trilaciclib-in-clinical-lung-cancer\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.med.unc.edu\/medicine\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"G1 Therapeutics Announces Publication of Pooled Results from Pivotal Clinical Program of COSELA\u2122 (trilaciclib) in Clinical Lung Cancer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#website\",\"url\":\"https:\/\/www.med.unc.edu\/medicine\/\",\"name\":\"Department of Medicine\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.med.unc.edu\/medicine\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/9a358414a53d5237f9ba3f8daa55c529\",\"name\":\"Kim Morris\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/95c34b3e4d55a602b94260bccc6350c2ddfdde901530a734fe6c8fa9e3a5d399?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/95c34b3e4d55a602b94260bccc6350c2ddfdde901530a734fe6c8fa9e3a5d399?s=96&d=mm&r=g\",\"caption\":\"Kim Morris\"},\"description\":\"Medicine - Dept of\",\"url\":\"https:\/\/www.med.unc.edu\/medicine\/news\/author\/kcmorris\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"G1 Therapeutics Announces Publication of Pooled Results from Pivotal Clinical Program of COSELA\u2122 (trilaciclib) in Clinical Lung Cancer | Department of Medicine","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.med.unc.edu\/medicine\/news\/g1-therapeutics-announces-publication-of-pooled-results-from-pivotal-clinical-program-of-cosela-trilaciclib-in-clinical-lung-cancer\/","og_locale":"en_US","og_type":"article","og_title":"G1 Therapeutics Announces Publication of Pooled Results from Pivotal Clinical Program of COSELA\u2122 (trilaciclib) in Clinical Lung Cancer | Department of Medicine","og_description":"G1 Therapeutics, Inc., a commercial-stage oncology company, announced that the peer-reviewed journal of Clinical Lung Cancer published the final pooled results from three clinical trials of COSELA\u2122 (trilaciclib) in extensive-stage small cell lung cancer (ES-SCLC). \u201cCancer patients have two major sources of physical suffering &#8211; the cancer itself and the side effects of chemotherapy,\u201d said &hellip; Read more","og_url":"https:\/\/www.med.unc.edu\/medicine\/news\/g1-therapeutics-announces-publication-of-pooled-results-from-pivotal-clinical-program-of-cosela-trilaciclib-in-clinical-lung-cancer\/","og_site_name":"Department of Medicine","article_publisher":"https:\/\/www.facebook.com\/UNCDeptMedicine","article_published_time":"2021-04-30T02:55:10+00:00","article_modified_time":"2023-06-06T22:09:00+00:00","og_image":[{"width":867,"height":929,"url":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2020\/03\/jared-weiss-LCCC-photo-e1640101386432.jpg","type":"image\/jpeg"}],"author":"Kim Morris","twitter_card":"summary_large_image","twitter_creator":"@uncdeptmedicine","twitter_site":"@uncdeptmedicine","twitter_misc":{"Written by":"Kim Morris","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.med.unc.edu\/medicine\/news\/g1-therapeutics-announces-publication-of-pooled-results-from-pivotal-clinical-program-of-cosela-trilaciclib-in-clinical-lung-cancer\/#article","isPartOf":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/g1-therapeutics-announces-publication-of-pooled-results-from-pivotal-clinical-program-of-cosela-trilaciclib-in-clinical-lung-cancer\/"},"author":{"name":"Kim Morris","@id":"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/9a358414a53d5237f9ba3f8daa55c529"},"headline":"G1 Therapeutics Announces Publication of Pooled Results from Pivotal Clinical Program of COSELA\u2122 (trilaciclib) in Clinical Lung Cancer","datePublished":"2021-04-30T02:55:10+00:00","dateModified":"2023-06-06T22:09:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/g1-therapeutics-announces-publication-of-pooled-results-from-pivotal-clinical-program-of-cosela-trilaciclib-in-clinical-lung-cancer\/"},"wordCount":278,"image":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/g1-therapeutics-announces-publication-of-pooled-results-from-pivotal-clinical-program-of-cosela-trilaciclib-in-clinical-lung-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2020\/03\/jared-weiss-LCCC-photo-e1640101386432.jpg","keywords":["2021"],"articleSection":["News","Oncology"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.med.unc.edu\/medicine\/news\/g1-therapeutics-announces-publication-of-pooled-results-from-pivotal-clinical-program-of-cosela-trilaciclib-in-clinical-lung-cancer\/","url":"https:\/\/www.med.unc.edu\/medicine\/news\/g1-therapeutics-announces-publication-of-pooled-results-from-pivotal-clinical-program-of-cosela-trilaciclib-in-clinical-lung-cancer\/","name":"G1 Therapeutics Announces Publication of Pooled Results from Pivotal Clinical Program of COSELA\u2122 (trilaciclib) in Clinical Lung Cancer | Department of Medicine","isPartOf":{"@id":"https:\/\/www.med.unc.edu\/medicine\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/g1-therapeutics-announces-publication-of-pooled-results-from-pivotal-clinical-program-of-cosela-trilaciclib-in-clinical-lung-cancer\/#primaryimage"},"image":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/g1-therapeutics-announces-publication-of-pooled-results-from-pivotal-clinical-program-of-cosela-trilaciclib-in-clinical-lung-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2020\/03\/jared-weiss-LCCC-photo-e1640101386432.jpg","datePublished":"2021-04-30T02:55:10+00:00","dateModified":"2023-06-06T22:09:00+00:00","author":{"@id":"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/9a358414a53d5237f9ba3f8daa55c529"},"breadcrumb":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/g1-therapeutics-announces-publication-of-pooled-results-from-pivotal-clinical-program-of-cosela-trilaciclib-in-clinical-lung-cancer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.med.unc.edu\/medicine\/news\/g1-therapeutics-announces-publication-of-pooled-results-from-pivotal-clinical-program-of-cosela-trilaciclib-in-clinical-lung-cancer\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.med.unc.edu\/medicine\/news\/g1-therapeutics-announces-publication-of-pooled-results-from-pivotal-clinical-program-of-cosela-trilaciclib-in-clinical-lung-cancer\/#primaryimage","url":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2020\/03\/jared-weiss-LCCC-photo-e1640101386432.jpg","contentUrl":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2020\/03\/jared-weiss-LCCC-photo-e1640101386432.jpg","width":867,"height":929,"caption":"Jared Weiss, MD"},{"@type":"BreadcrumbList","@id":"https:\/\/www.med.unc.edu\/medicine\/news\/g1-therapeutics-announces-publication-of-pooled-results-from-pivotal-clinical-program-of-cosela-trilaciclib-in-clinical-lung-cancer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.med.unc.edu\/medicine\/"},{"@type":"ListItem","position":2,"name":"G1 Therapeutics Announces Publication of Pooled Results from Pivotal Clinical Program of COSELA\u2122 (trilaciclib) in Clinical Lung Cancer"}]},{"@type":"WebSite","@id":"https:\/\/www.med.unc.edu\/medicine\/#website","url":"https:\/\/www.med.unc.edu\/medicine\/","name":"Department of Medicine","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.med.unc.edu\/medicine\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/9a358414a53d5237f9ba3f8daa55c529","name":"Kim Morris","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/95c34b3e4d55a602b94260bccc6350c2ddfdde901530a734fe6c8fa9e3a5d399?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/95c34b3e4d55a602b94260bccc6350c2ddfdde901530a734fe6c8fa9e3a5d399?s=96&d=mm&r=g","caption":"Kim Morris"},"description":"Medicine - Dept of","url":"https:\/\/www.med.unc.edu\/medicine\/news\/author\/kcmorris\/"}]}},"featured_image":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2020\/03\/jared-weiss-LCCC-photo-e1640101386432.jpg","featured_image_medium":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2020\/03\/jared-weiss-LCCC-photo-e1640101386432-280x300.jpg","featured_image_medium_large":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2020\/03\/jared-weiss-LCCC-photo-e1640101386432-768x823.jpg","featured_image_large":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2020\/03\/jared-weiss-LCCC-photo-1024x793.jpg","featured_image_thumbnail":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2020\/03\/jared-weiss-LCCC-photo-e1640101386432-150x150.jpg","featured_image_alt":"jared-weiss-newsworthy-december-2021","category_details":[{"name":"News","link":"https:\/\/www.med.unc.edu\/medicine\/news\/category\/news\/"},{"name":"Oncology","link":"https:\/\/www.med.unc.edu\/medicine\/news\/category\/oncology\/"}],"tag_details":[{"name":"2021","link":"https:\/\/www.med.unc.edu\/medicine\/news\/tag\/2021\/"}],"_links_to":[],"_links_to_target":[],"_links":{"self":[{"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/posts\/51041","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/users\/69419"}],"replies":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/comments?post=51041"}],"version-history":[{"count":0,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/posts\/51041\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/media\/41040"}],"wp:attachment":[{"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/media?parent=51041"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/categories?post=51041"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/tags?post=51041"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}